Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.520
+0.010 (0.66%)
At close: Jul 7, 2025, 4:00 PM
1.540
+0.020 (1.32%)
After-hours: Jul 7, 2025, 4:04 PM EDT
Rein Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 7.43 | 12.87 | 17.31 | 5.19 | 3.6 | 7.05 | Upgrade
|
Short-Term Investments | - | - | - | 16.05 | 42.33 | 6.76 | Upgrade
|
Cash & Short-Term Investments | 7.43 | 12.87 | 17.31 | 21.24 | 45.93 | 13.81 | Upgrade
|
Cash Growth | -38.32% | -25.69% | -18.50% | -53.75% | 232.73% | -24.47% | Upgrade
|
Prepaid Expenses | - | - | - | 0.61 | 2.22 | 1.93 | Upgrade
|
Restricted Cash | - | - | 0.03 | 0.03 | 0.03 | 0.59 | Upgrade
|
Other Current Assets | 0.9 | 0.79 | 0.93 | - | - | - | Upgrade
|
Total Current Assets | 8.33 | 13.66 | 18.27 | 21.87 | 48.18 | 16.33 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0.02 | 0.11 | 0.28 | 0.02 | Upgrade
|
Goodwill | 6.33 | 6.33 | 6.33 | - | - | - | Upgrade
|
Other Intangible Assets | 42.2 | 42.2 | 79.2 | - | - | - | Upgrade
|
Long-Term Deferred Charges | - | - | 2.14 | - | - | - | Upgrade
|
Other Long-Term Assets | 0.77 | 0 | 0.05 | 0.02 | 0.02 | - | Upgrade
|
Total Assets | 57.63 | 62.19 | 106.01 | 22.01 | 48.48 | 16.34 | Upgrade
|
Accounts Payable | 1.15 | 0.91 | 1.19 | 1.72 | 1.21 | 1.6 | Upgrade
|
Accrued Expenses | 4.66 | 4.72 | 2.94 | 1.45 | 3.15 | 1.95 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 0.17 | Upgrade
|
Current Portion of Leases | - | - | 0.05 | 0.03 | 0.09 | - | Upgrade
|
Other Current Liabilities | 0.16 | 0.12 | 0.21 | 0.18 | 0.06 | 0.24 | Upgrade
|
Total Current Liabilities | 5.98 | 5.75 | 4.39 | 3.38 | 4.51 | 3.96 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.22 | Upgrade
|
Long-Term Leases | - | - | - | - | 0.07 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.77 | 1.77 | 3.33 | - | - | - | Upgrade
|
Other Long-Term Liabilities | - | 0.28 | - | - | - | - | Upgrade
|
Total Liabilities | 7.75 | 7.8 | 7.71 | 3.38 | 4.58 | 4.18 | Upgrade
|
Common Stock | 0.11 | 0.11 | 0.09 | 0.09 | 0.09 | 0.04 | Upgrade
|
Additional Paid-In Capital | 361.7 | 360.7 | 295.38 | 291.37 | 289.28 | 231.41 | Upgrade
|
Retained Earnings | -356.9 | -351.4 | -288.52 | -272.79 | -245.46 | -219.29 | Upgrade
|
Comprehensive Income & Other | -0.03 | -0.02 | -0.06 | -0.05 | -0.01 | -0 | Upgrade
|
Total Common Equity | 4.87 | 9.39 | 6.89 | 18.62 | 43.9 | 12.16 | Upgrade
|
Shareholders' Equity | 49.88 | 54.39 | 98.3 | 18.62 | 43.9 | 12.16 | Upgrade
|
Total Liabilities & Equity | 57.63 | 62.19 | 106.01 | 22.01 | 48.48 | 16.34 | Upgrade
|
Total Debt | - | - | 0.05 | 0.03 | 0.16 | 0.39 | Upgrade
|
Net Cash (Debt) | 7.43 | 12.87 | 17.27 | 21.21 | 45.77 | 13.42 | Upgrade
|
Net Cash Growth | -38.32% | -25.49% | -18.60% | -53.66% | 241.12% | 1.30% | Upgrade
|
Net Cash Per Share | 0.35 | 0.72 | 3.75 | 4.67 | 10.31 | 7.70 | Upgrade
|
Filing Date Shares Outstanding | 22.15 | 21.99 | 16.97 | 4.54 | 4.53 | 4.51 | Upgrade
|
Total Common Shares Outstanding | 22.01 | 21.67 | 4.89 | 4.54 | 4.53 | 2.19 | Upgrade
|
Working Capital | 2.35 | 7.91 | 13.88 | 18.49 | 43.67 | 12.37 | Upgrade
|
Book Value Per Share | 0.22 | 0.43 | 1.41 | 4.10 | 9.69 | 5.55 | Upgrade
|
Tangible Book Value | -43.66 | -39.14 | -78.64 | 18.62 | 43.9 | 12.16 | Upgrade
|
Tangible Book Value Per Share | -1.98 | -1.81 | -16.10 | 4.10 | 9.69 | 5.55 | Upgrade
|
Machinery | - | - | - | 0.34 | 0.34 | - | Upgrade
|
Updated Apr 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.